CRISPR updates early-stage trial data for heart disease therapy

CRISPR Therapeutics (CRSP) on Saturday announced new results from a Phase 1 trial for CTX310, an in vivo gene editing therapy ...
Tech Times

CRISPR Technology Explained: The Science of Gene Editing, DNA Modification, and Genetic Engineering Ethics Uncovered

Explore CRISPR technology explained, gene editing science, DNA modification, and genetic engineering ethics—discover how ...

CRISPR gene-editing works to reduce high cholesterol in a new study

An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...

CRISPR Therapeutics Announces Positive Phase 1 Clinical Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and Lipid Lowering

Data presented in a late-breaking presentation at the American Heart Association (AHA) Scientific Sessions 2025- -Phase 1 ...
HealthTech

The CRISPR Revolution: What Does it Mean for Us?

Science and medicine are incredibly amazing. Thanks to modern science and medicine, we now have lifespans far beyond our Dark Age predecessors, living until ripe old age and enjoying the fruits of our ...
Nature

‘Biotech Barbie’ says the time has come to consider CRISPR babies. Do scientists agree?

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
Nasdaq

CRISPR Therapeutics's Options: A Look at What the Big Money is Thinking

Deep-pocketed investors have adopted a bearish approach towards CRISPR Therapeutics (NASDAQ:CRSP), and it's something market players shouldn't ignore. Our tracking of public options records at ...
Technology Networks

CRISPR Study Reveals Gene Linking Down Syndrome to Heart Disease

A new study has revealed that the gene HMGN1 is a key driver of congenital heart defects (CHDs) in Down syndrome. Using ...
Fierce Biotech

Intellia pauses phase 3 CRISPR trials after patient is hospitalized

Intellia paused both trials after receiving a report of grade 4 liver enzymes and increased total bilirubin in a patient in ...
Nasdaq

Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know

CRISPR Therapeutics AG (CRSP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...